HHS Report Finds FDA Postmarket Cybersecurity Lacking, FDA Fires Back

November 08, 2018
FDA and the HHS Office of Inspector General are butting heads over whether the agency is equipped to address postmarket cybersecurity risks to medical devices. A report released by the OIG last month says FDA has a long way to go on addressing such risks, pointing out a lack of written procedures for handling cybersecurity events, for sharing information between stakeholders, and for recalling vulnerable devices, as well as a lack of testing of the agency’s ability to respond to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.